Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to April 2026, from the company's annual filing with the SEC.
| Salesyearly sales | $63.2M |
| Sales growthchange from the year before | -9.4% |
| Gross marginshare of sales left after the direct cost of what it sells | 29.1% |
| Operating marginshare of sales left after running the business | -4.7% |
| Net marginshare of sales kept as profit | 0.0% |
| Free-cash-flow marginspare cash generated per $100 of sales | -2.5% |
| Return on invested capitalprofit made on each $100 put into the business | -3.9% |
| Return on equityprofit vs. shareholders' accounting value | 0.0% |
| Interest coverhow many times profit covers interest payments | -34.5x |
| Change in share countnegative = the company is buying back its shares | +1.8% |
1 insider sold $37.5M on the open market.
| Edenbrook Capital, LLC; Edenbrook Long Only Value Fund, Lp; Brolin JonathanDirector · 10% owner | SoldJul 28 | 652,174 shat $57.50 · $37.5M |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy